Fanconi Anemia Complementation Group M (FANCM) Kits ELISA

The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). De plus, nous expédions FANCM Anticorps (82) et et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
FANCM 57697 Q8IYD8
FANCM 104806 Q8BGE5
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne

Top FANCM Kits ELISA sur

Showing 2 out of 4 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Fournisseur Livraison Prix Détails
Souris < 46.9 pg/mL 78 pg/mL - 5000 pg/mL   96 Tests Connectez-vous pour afficher 11 to 18 Days
Humain < 0.188 ng/mL 0.313 ng/mL - 20 ng/mL   96 Tests Connectez-vous pour afficher 11 to 18 Days

Plus Kits ELISA pour FANCM partenaires d'interaction

Human Fanconi Anemia Complementation Group M (FANCM) interaction partners

  1. Our study of the Polish and Ukrainian populations has identified a carrier frequency of truncating mutations in FANCM and breast cancer susceptibility.

  2. FANCM expression is a prognostic factor for overall survival in luminal B breast cancer in Chinese patients.

  3. Loss-of-function mutations in FANCM cause a cancer predisposition syndrome clinically distinct from bona fide FA. Care should be taken with chemotherapy and radiation treatments in these patients due to expected acute toxicity.

  4. Our data indicate that biallelic FANCM mutations do not cause classical FA, providing proof that FANCM is not a canonical FA gene. FANCM is a breast cancer-predisposing gene. Mutation testing of FANCM might be considered for individuals with the above-described clinical features.

  5. Two FANCM truncating mutations, the c.1432C>T (p.Arg478Ter) and c.1972C>T (p.Arg658Ter), were identified in two Male Breast Cancer cases (0.7%). When specifically considering cases at increased genetic risk for BC, FANCM mutation frequency raises up to 1%. Rare FANCM truncating mutations, other than c.5101C>T and c.5791C>T, may have a role in MBC susceptibility.

  6. Mutation in FANCM gene is associated with non-syndromic primary ovarian insufficiency.

  7. These results support the role of FANCM as a breast cancer susceptibility gene, particularly for triple-negative breast cancer.

  8. FANCM is actively recruited to the alternative lengthening of telomeres that are experiencing replication stress.

  9. we demonstrated that FANCM is a direct target of miR146a

  10. This case-control study included 2047 BRCA1 and BRCA2-negative familial breast cancer cases and 2187 controls and revealed an association of FANCM mutations with breast cancer. More pronounced associations were identified for early-onset (before age 51 years) breast cancer and triple-negative breast cancer.

  11. FANCM c.5101C > T nonsense mutation carriers have a reduced breast cancer survival but postoperative radiotherapy may diminish this survival disadvantage.

  12. we provide evidence for the first time showing that the common p.Arg1931* loss-of-function variant in FANCM is a risk factor for familial breast cancer.

  13. FANCM c.5101C>T mutation was not identified in Pakistani triple-negative breast cancer patients

  14. MHF facilitates the processing of multiple types of branched DNAs by the DNA translocase FANCM. MHF complex recognizes branched DNA and stimulates FANCM activity at such a structure to promote genome maintenance.

  15. FANCM is a breast cancer susceptibility gene, mutations in which confer a particularly strong predisposition for triple-negative breast cancer

  16. The MHF complex, which is a heterotetramer that comprises two MHF1-MHF2 heterodimers, is remodeled by FANCM to favor recognition of branched DNA over dsDNA.

  17. The FANCM translocase domain lies in proximity to C-terminal domain and binding fork DNA structures stimulate its ATPase activity.

  18. The traverse frequency was strongly reduced by inactivation of the translocase and DNA binding activities of the FANCM/MHF complex.

  19. Variations of several key residues and the electrostatic property at the active-site region render a catalytically inactive nuclease domain of FANCM, accounting for the lack of nuclease activity.

  20. Genotoxic stress-induced FANCM phosphorylation is ATR-dependent.

Mouse (Murine) Fanconi Anemia Complementation Group M (FANCM) interaction partners

  1. Suppression of Rad52 expression in combination with FANCM knockout drastically reduces cell and tumor growth, suggesting a synthetic lethality interaction between these two genes.

  2. Fancm(Delta2/Delta2) mice also showed unique features atypical for Fanconi anemia mice, including underrepresentation of female Fancm(Delta2/Delta2) mice and decreased overall and tumor-free survival.

FANCM profil antigène

Antigen Summary

The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity\; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M.

Gene names and symbols associated with FANCM

  • Fanconi anemia complementation group M (FANCM) anticorps
  • hypothetical protein (PGTG_17854) anticorps
  • Fanconi anemia, complementation group M (Fancm) anticorps
  • AI427100 anticorps
  • C730036B14Rik anticorps
  • D12Ertd364e anticorps
  • FAAP250 anticorps
  • KIAA1596 anticorps

Protein level used designations for FANCM

Fanconi anemia complementation group M , fanconi anemia complementation group M , ATP-dependent RNA helicase FANCM , Fanconi anemia group M protein , fanconi anemia-associated polypeptide of 250 kDa , protein Hef ortholog , Fanconi anemia group M protein homolog

513626 Bos taurus
10531976 Puccinia graminis f. sp. tritici CRL 75-36-700-3
57697 Homo sapiens
104806 Mus musculus
Fournisseurs de qualité sélectionnés pour FANCM (FANCM) Kits ELISA
Avez-vous cherché autre chose?